Bio-Techne Showcases Innovative Cancer Screening Solutions
Innovating Cancer and Carrier Screening Solutions at AMP 2024
Bio-Techne Corporation (NASDAQ: TECH) has made an impressive announcement regarding its participation in the upcoming annual meeting and expo. This event, held by the Association for Molecular Pathology (AMP 2024), is an excellent opportunity for the company to present its pioneering advancements in assays and kits tailored for cancer monitoring and carrier screening.
Key Presentations and Workshops at the Expo
One of the highlights will be the presence of Asuragen, a brand under Bio-Techne, which will exhibit at booth #811. They will focus on the company’s innovative products that enhance laboratory efficiency in diagnosing conditions such as breast cancer. Dr. Matt McManus, President of Bio-Techne's Diagnostics & Spatial Biology Segment, emphasized their commitment to addressing the latest challenges and advancements in molecular diagnostics.
Workshops Innovating Diagnostic Processes
As part of the educational initiatives at the expo, several workshops are scheduled. One significant workshop is titled "ESR1 & Beyond: Leveraging Exosomes for Highly-Sensitive Variant Detection on qPCR." This session will focus on the QuantideX® qPCR ESR1 exoMutation Kit. The workshop aims at demonstrating how to achieve a remarkable analytical sensitivity of ?0.1% across various ESR1 mutations, thus showcasing the power of circulating free DNA (cfDNA) and exosomal RNA.
Advanced Carrier Screening Techniques
Another workshop of great importance is "Long-Range PCR Meets Long-Read Sequencing: An Assay for 11 Hard-to-Decipher, High-Frequency Carrier Screening Associated Genes." Here, the focus will be on the AmplideX® Nanopore Carrier Plus Kit, which combines advanced PCR techniques with Oxford Nanopore technology to explore complex genetic alterations, enhancing the performance of genetic tests.
Engaging Discussions on Laboratory Compliance
In addition to the workshops, Bio-Techne is also organizing a fireside chat focused on the current landscape of laboratory-developed tests (LDT) and compliance with the FDA. It will enable laboratory leaders to share their perspectives and plans regarding the evolving regulatory environment. Discussions of this nature are crucial as they navigate the uncertain terrain of LDT compliance.
Poster Sessions Highlighting Recent Research
Various poster sessions will be available throughout the event. Topics like the verification of RT-qPCR assays for liquid biopsy surveillance and the application of nanopore sequencing assays for genotyping will be addressed by leading experts in the field.
Networking and Opportunities
Attendees visiting the Asuragen booth will also receive complimentary professional headshots, adding an extra layer of value to their interaction with the Bio-Techne team. This commitment to customer engagement emphasizes the company's dedication to fostering connections within the scientific community.
About Bio-Techne Corporation
As a global leader in life sciences, Bio-Techne (NASDAQ: TECH) has established itself as a pivotal player in providing cutting-edge tools and bioactive reagents vital for research and diagnostics. The company prides itself on its ability to support scientific research and clinical diagnostics, which are critical in understanding disease mechanisms and developing new therapeutic approaches. With a portfolio packed with valuable products and a workforce exceeding 3,100 employees, Bio-Techne continues to push boundaries in scientific innovation.
Frequently Asked Questions
What is the main focus of Bio-Techne at AMP 2024?
Bio-Techne is focused on showcasing novel solutions for cancer monitoring and carrier screening through innovative assays and workshops.
Where can I find Bio-Techne at the AMP 2024?
Visit the Asuragen booth #811 at the expo to learn more about their products and participate in various educational activities.
Who will lead the discussions on LDT compliance?
Dr. Jordan Laser from Asuragen will lead the fireside chat focusing on laboratory-developed test compliance strategies.
What workshops can attendees expect?
Attendees can participate in workshops that cover advanced molecular techniques such as qPCR for variant detection and nanopore sequencing for carrier screening.
What is the significance of the poster sessions?
The poster sessions will highlight recent research initiatives and techniques in genetic testing, fostering collaboration and awareness among attendees.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.